Specifically, the highest increase was observed in the circulating levels of Osteoprotegerin (OPG) and Osteoactivin, also known as Glycoprotein non-metastatic melanoma protein B (GPNMB), among people with T2D [13]. The gene discussed is GPNMB; the disease is type 2 diabetes mellitus.